nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—CYP2B6—Thiotepa—sarcoma	0.135	0.181	CbGbCtD
Ethinyl Estradiol—ABCB11—Vincristine—sarcoma	0.12	0.16	CbGbCtD
Ethinyl Estradiol—ABCB11—Doxorubicin—sarcoma	0.0747	0.1	CbGbCtD
Ethinyl Estradiol—ABCC2—Vincristine—sarcoma	0.0629	0.0841	CbGbCtD
Ethinyl Estradiol—ABCC2—Etoposide—sarcoma	0.0576	0.0771	CbGbCtD
Ethinyl Estradiol—CYP3A4—Thiotepa—sarcoma	0.0415	0.0555	CbGbCtD
Ethinyl Estradiol—ABCC2—Doxorubicin—sarcoma	0.0393	0.0526	CbGbCtD
Ethinyl Estradiol—ABCB1—Dactinomycin—sarcoma	0.0333	0.0445	CbGbCtD
Ethinyl Estradiol—ABCB1—Mitoxantrone—sarcoma	0.0298	0.0398	CbGbCtD
Ethinyl Estradiol—CYP2C8—Etoposide—sarcoma	0.0277	0.0371	CbGbCtD
Ethinyl Estradiol—CYP2B6—Doxorubicin—sarcoma	0.025	0.0334	CbGbCtD
Ethinyl Estradiol—ABCB1—Vincristine—sarcoma	0.0205	0.0274	CbGbCtD
Ethinyl Estradiol—ABCB1—Etoposide—sarcoma	0.0188	0.0251	CbGbCtD
Ethinyl Estradiol—CYP3A4—Mitoxantrone—sarcoma	0.0178	0.0239	CbGbCtD
Ethinyl Estradiol—AOX1—Effects of Nitric Oxide—MB—sarcoma	0.0157	0.221	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Doxorubicin—sarcoma	0.0128	0.0171	CbGbCtD
Ethinyl Estradiol—CYP3A4—Vincristine—sarcoma	0.0123	0.0164	CbGbCtD
Ethinyl Estradiol—CYP3A4—Etoposide—sarcoma	0.0113	0.0151	CbGbCtD
Ethinyl Estradiol—CYP3A4—Doxorubicin—sarcoma	0.00767	0.0103	CbGbCtD
Ethinyl Estradiol—AOX1—Effects of Nitric Oxide—HBA1—sarcoma	0.00567	0.0797	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Validated nuclear estrogen receptor beta network—SMARCB1—sarcoma	0.00502	0.0705	CbGpPWpGaD
Ethinyl Estradiol—SHBG—hindlimb—sarcoma	0.00452	0.0829	CbGeAlD
Ethinyl Estradiol—ESR1—periosteum—sarcoma	0.00447	0.082	CbGeAlD
Ethinyl Estradiol—SHBG—Nongenotropic Androgen signaling—PLCG1—sarcoma	0.00318	0.0447	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Ovarian Infertility Genes—GJA4—sarcoma	0.00285	0.0401	CbGpPWpGaD
Ethinyl Estradiol—ESR2—mammary gland—sarcoma	0.00194	0.0356	CbGeAlD
Ethinyl Estradiol—SLC10A1—seminal vesicle—sarcoma	0.00186	0.0341	CbGeAlD
Ethinyl Estradiol—NR1I2—liver—sarcoma	0.00184	0.0336	CbGeAlD
Ethinyl Estradiol—SHBG—Nongenotropic Androgen signaling—CREB1—sarcoma	0.00164	0.023	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.00142	0.0199	CbGpPWpGaD
Ethinyl Estradiol—ESR1—mammary gland—sarcoma	0.00133	0.0244	CbGeAlD
Ethinyl Estradiol—AOX1—myometrium—sarcoma	0.00133	0.0243	CbGeAlD
Ethinyl Estradiol—AOX1—seminal vesicle—sarcoma	0.0012	0.022	CbGeAlD
Ethinyl Estradiol—ESR2—hematopoietic system—sarcoma	0.00118	0.0217	CbGeAlD
Ethinyl Estradiol—SHBG—hematopoietic system—sarcoma	0.00115	0.0211	CbGeAlD
Ethinyl Estradiol—ESR2—connective tissue—sarcoma	0.00114	0.0209	CbGeAlD
Ethinyl Estradiol—SHBG—connective tissue—sarcoma	0.00111	0.0203	CbGeAlD
Ethinyl Estradiol—CYP2C8—mammary gland—sarcoma	0.0011	0.0201	CbGeAlD
Ethinyl Estradiol—SHBG—Nongenotropic Androgen signaling—SRC—sarcoma	0.00106	0.0148	CbGpPWpGaD
Ethinyl Estradiol—ESR2—smooth muscle tissue—sarcoma	0.00104	0.0191	CbGeAlD
Ethinyl Estradiol—ESR1—LKB1 signaling events—EZR—sarcoma	0.00101	0.0142	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—testis—sarcoma	0.00097	0.0178	CbGeAlD
Ethinyl Estradiol—ESR1—FOXA1 transcription factor network—COL18A1—sarcoma	0.000963	0.0135	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—testis—sarcoma	0.000959	0.0176	CbGeAlD
Ethinyl Estradiol—ESR1—myometrium—sarcoma	0.000943	0.0173	CbGeAlD
Ethinyl Estradiol—SLC10A1—liver—sarcoma	0.000917	0.0168	CbGeAlD
Ethinyl Estradiol—ESR1—embryo—sarcoma	0.000907	0.0166	CbGeAlD
Ethinyl Estradiol—ABCB11—liver—sarcoma	0.000906	0.0166	CbGeAlD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—MITF—sarcoma	0.000905	0.0127	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—IGF1R—sarcoma	0.000897	0.0126	CbGpPWpGaD
Ethinyl Estradiol—ESR2—uterus—sarcoma	0.000893	0.0164	CbGeAlD
Ethinyl Estradiol—SHBG—uterus—sarcoma	0.000868	0.0159	CbGeAlD
Ethinyl Estradiol—AOX1—cardiac atrium—sarcoma	0.000864	0.0158	CbGeAlD
Ethinyl Estradiol—AOX1—uterus—sarcoma	0.00086	0.0158	CbGeAlD
Ethinyl Estradiol—ESR2—lymphoid tissue—sarcoma	0.000833	0.0153	CbGeAlD
Ethinyl Estradiol—ESR1—hematopoietic system—sarcoma	0.00081	0.0148	CbGeAlD
Ethinyl Estradiol—ESR1—connective tissue—sarcoma	0.00078	0.0143	CbGeAlD
Ethinyl Estradiol—AOX1—tendon—sarcoma	0.000753	0.0138	CbGeAlD
Ethinyl Estradiol—SHBG—Nongenotropic Androgen signaling—HRAS—sarcoma	0.000744	0.0104	CbGpPWpGaD
Ethinyl Estradiol—SHBG—bone marrow—sarcoma	0.000737	0.0135	CbGeAlD
Ethinyl Estradiol—ESR1—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.000714	0.01	CbGpPWpGaD
Ethinyl Estradiol—ESR1—smooth muscle tissue—sarcoma	0.000713	0.0131	CbGeAlD
Ethinyl Estradiol—CYP2C8—hematopoietic system—sarcoma	0.000667	0.0122	CbGeAlD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—sarcoma	0.000654	0.00919	CbGpPWpGaD
Ethinyl Estradiol—ESR2—testis—sarcoma	0.000648	0.0119	CbGeAlD
Ethinyl Estradiol—SHBG—testis—sarcoma	0.00063	0.0115	CbGeAlD
Ethinyl Estradiol—AOX1—testis—sarcoma	0.000624	0.0114	CbGeAlD
Ethinyl Estradiol—ESR2—liver—sarcoma	0.000613	0.0112	CbGeAlD
Ethinyl Estradiol—ESR1—uterus—sarcoma	0.000612	0.0112	CbGeAlD
Ethinyl Estradiol—CYP2B6—hematopoietic system—sarcoma	0.000599	0.011	CbGeAlD
Ethinyl Estradiol—SHBG—liver—sarcoma	0.000596	0.0109	CbGeAlD
Ethinyl Estradiol—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000591	0.0083	CbGpPWpGaD
Ethinyl Estradiol—AOX1—liver—sarcoma	0.00059	0.0108	CbGeAlD
Ethinyl Estradiol—ABCC2—tendon—sarcoma	0.000589	0.0108	CbGeAlD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—MMP2—sarcoma	0.000577	0.0081	CbGpPWpGaD
Ethinyl Estradiol—ESR1—lymphoid tissue—sarcoma	0.00057	0.0105	CbGeAlD
Ethinyl Estradiol—ESR1—Estrogen Receptor Pathway—JUN—sarcoma	0.000563	0.00791	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—WT1—sarcoma	0.000532	0.00747	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—skin of body—sarcoma	0.00052	0.00954	CbGeAlD
Ethinyl Estradiol—AOX1—Tryptophan metabolism—MDM2—sarcoma	0.000509	0.00715	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	0.000498	0.00699	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Estrogen signaling pathway—CREB1—sarcoma	0.000496	0.00697	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—testis—sarcoma	0.000488	0.00893	CbGeAlD
Ethinyl Estradiol—ESR2—lymph node—sarcoma	0.00047	0.00861	CbGeAlD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000462	0.00649	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—liver—sarcoma	0.000461	0.00845	CbGeAlD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—sarcoma	0.000452	0.00635	CbGpPWpGaD
Ethinyl Estradiol—AOX1—lymph node—sarcoma	0.000452	0.00829	CbGeAlD
Ethinyl Estradiol—CYP3A4—hematopoietic system—sarcoma	0.000452	0.00828	CbGeAlD
Ethinyl Estradiol—ESR1—testis—sarcoma	0.000444	0.00813	CbGeAlD
Ethinyl Estradiol—CYP2B6—lymphoid tissue—sarcoma	0.000421	0.00772	CbGeAlD
Ethinyl Estradiol—ESR1—liver—sarcoma	0.00042	0.00769	CbGeAlD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.0004	0.00561	CbGpPWpGaD
Ethinyl Estradiol—Hypoaesthesia—Etoposide—sarcoma	0.00039	0.00308	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Etoposide—sarcoma	0.000387	0.00306	CcSEcCtD
Ethinyl Estradiol—Infection—Thiotepa—sarcoma	0.000385	0.00304	CcSEcCtD
Ethinyl Estradiol—Oedema—Dactinomycin—sarcoma	0.000385	0.00304	CcSEcCtD
Ethinyl Estradiol—Fluid retention—Doxorubicin—sarcoma	0.000384	0.00303	CcSEcCtD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.000384	0.0054	CbGpPWpGaD
Ethinyl Estradiol—Urethral disorder—Etoposide—sarcoma	0.000384	0.00303	CcSEcCtD
Ethinyl Estradiol—Infection—Dactinomycin—sarcoma	0.000382	0.00302	CcSEcCtD
Ethinyl Estradiol—Vaginal infection—Doxorubicin—sarcoma	0.000382	0.00302	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Mitoxantrone—sarcoma	0.000381	0.00301	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Thiotepa—sarcoma	0.00038	0.003	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Thiotepa—sarcoma	0.000377	0.00297	CcSEcCtD
Ethinyl Estradiol—CYP2B6—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000377	0.00529	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—PLCG1—sarcoma	0.000374	0.00526	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—myometrium—sarcoma	0.000373	0.00683	CbGeAlD
Ethinyl Estradiol—Erythema multiforme—Etoposide—sarcoma	0.000371	0.00293	CcSEcCtD
Ethinyl Estradiol—Malaise—Mitoxantrone—sarcoma	0.00037	0.00292	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Etoposide—sarcoma	0.000366	0.00289	CcSEcCtD
Ethinyl Estradiol—Neoplasm—Doxorubicin—sarcoma	0.000366	0.00289	CcSEcCtD
Ethinyl Estradiol—Bladder pain—Doxorubicin—sarcoma	0.000366	0.00289	CcSEcCtD
Ethinyl Estradiol—CYP2C8—testis—sarcoma	0.000366	0.0067	CbGeAlD
Ethinyl Estradiol—ABCB1—embryo—sarcoma	0.000358	0.00657	CbGeAlD
Ethinyl Estradiol—Cough—Mitoxantrone—sarcoma	0.000358	0.00283	CcSEcCtD
Ethinyl Estradiol—ESR1—Estrogen signaling pathway—JUN—sarcoma	0.000357	0.00501	CbGpPWpGaD
Ethinyl Estradiol—Angiopathy—Etoposide—sarcoma	0.000356	0.00281	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—CREB1—sarcoma	0.000354	0.00498	CbGpPWpGaD
Ethinyl Estradiol—Immune system disorder—Etoposide—sarcoma	0.000354	0.0028	CcSEcCtD
Ethinyl Estradiol—Eczema—Epirubicin—sarcoma	0.000353	0.00279	CcSEcCtD
Ethinyl Estradiol—ABCC2—lymph node—sarcoma	0.000353	0.00648	CbGeAlD
Ethinyl Estradiol—Anxiety—Mitoxantrone—sarcoma	0.000348	0.00275	CcSEcCtD
Ethinyl Estradiol—Alopecia—Etoposide—sarcoma	0.000346	0.00273	CcSEcCtD
Ethinyl Estradiol—CYP2C8—liver—sarcoma	0.000346	0.00634	CbGeAlD
Ethinyl Estradiol—Discomfort—Mitoxantrone—sarcoma	0.000345	0.00272	CcSEcCtD
Ethinyl Estradiol—Oedema—Vincristine—sarcoma	0.000344	0.00271	CcSEcCtD
Ethinyl Estradiol—Infection—Vincristine—sarcoma	0.000342	0.0027	CcSEcCtD
Ethinyl Estradiol—Hot flush—Epirubicin—sarcoma	0.00034	0.00268	CcSEcCtD
Ethinyl Estradiol—Increased appetite—Epirubicin—sarcoma	0.000338	0.00267	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Vincristine—sarcoma	0.000337	0.00266	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Epirubicin—sarcoma	0.000337	0.00266	CcSEcCtD
Ethinyl Estradiol—ABCB1—seminal vesicle—sarcoma	0.000337	0.00617	CbGeAlD
Ethinyl Estradiol—Oedema—Mitoxantrone—sarcoma	0.000335	0.00264	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Thiotepa—sarcoma	0.000335	0.00264	CcSEcCtD
Ethinyl Estradiol—Fatigue—Thiotepa—sarcoma	0.000334	0.00264	CcSEcCtD
Ethinyl Estradiol—Infection—Mitoxantrone—sarcoma	0.000333	0.00263	CcSEcCtD
Ethinyl Estradiol—Fatigue—Dactinomycin—sarcoma	0.000332	0.00262	CcSEcCtD
Ethinyl Estradiol—Constipation—Thiotepa—sarcoma	0.000332	0.00262	CcSEcCtD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.000331	0.00465	CbGpPWpGaD
Ethinyl Estradiol—Back pain—Etoposide—sarcoma	0.00033	0.00261	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Etoposide—sarcoma	0.000328	0.00259	CcSEcCtD
Ethinyl Estradiol—CYP2B6—testis—sarcoma	0.000328	0.00601	CbGeAlD
Ethinyl Estradiol—Eczema—Doxorubicin—sarcoma	0.000327	0.00258	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Mitoxantrone—sarcoma	0.000325	0.00257	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Epirubicin—sarcoma	0.000324	0.00256	CcSEcCtD
Ethinyl Estradiol—ESR1—lymph node—sarcoma	0.000322	0.0059	CbGeAlD
Ethinyl Estradiol—ABCB1—hematopoietic system—sarcoma	0.00032	0.00586	CbGeAlD
Ethinyl Estradiol—Feeling abnormal—Thiotepa—sarcoma	0.00032	0.00252	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Epirubicin—sarcoma	0.000318	0.00251	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Dactinomycin—sarcoma	0.000317	0.0025	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Thiotepa—sarcoma	0.000317	0.0025	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Etoposide—sarcoma	0.000317	0.0025	CcSEcCtD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—PDGFRA—sarcoma	0.000316	0.00444	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal pain—Dactinomycin—sarcoma	0.000315	0.00248	CcSEcCtD
Ethinyl Estradiol—Hot flush—Doxorubicin—sarcoma	0.000314	0.00248	CcSEcCtD
Ethinyl Estradiol—Increased appetite—Doxorubicin—sarcoma	0.000313	0.00247	CcSEcCtD
Ethinyl Estradiol—Migraine—Epirubicin—sarcoma	0.000313	0.00247	CcSEcCtD
Ethinyl Estradiol—Affect lability—Epirubicin—sarcoma	0.000313	0.00247	CcSEcCtD
Ethinyl Estradiol—ESR2—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000313	0.00439	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000312	0.00438	CbGpPWpGaD
Ethinyl Estradiol—Menopausal symptoms—Doxorubicin—sarcoma	0.000312	0.00246	CcSEcCtD
Ethinyl Estradiol—CYP2B6—liver—sarcoma	0.00031	0.00568	CbGeAlD
Ethinyl Estradiol—Urticaria—Thiotepa—sarcoma	0.000308	0.00243	CcSEcCtD
Ethinyl Estradiol—Malaise—Etoposide—sarcoma	0.000308	0.00243	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Thiotepa—sarcoma	0.000307	0.00242	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Thiotepa—sarcoma	0.000307	0.00242	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Dactinomycin—sarcoma	0.000304	0.0024	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Dactinomycin—sarcoma	0.000304	0.0024	CcSEcCtD
Ethinyl Estradiol—Mood swings—Epirubicin—sarcoma	0.000301	0.00238	CcSEcCtD
Ethinyl Estradiol—ESR1—LKB1 signaling events—CREB1—sarcoma	0.000301	0.00422	CbGpPWpGaD
Ethinyl Estradiol—Cerebrovascular accident—Doxorubicin—sarcoma	0.0003	0.00237	CcSEcCtD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000298	0.00419	CbGpPWpGaD
Ethinyl Estradiol—Cough—Etoposide—sarcoma	0.000298	0.00235	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Vincristine—sarcoma	0.000297	0.00234	CcSEcCtD
Ethinyl Estradiol—Fatigue—Vincristine—sarcoma	0.000296	0.00234	CcSEcCtD
Ethinyl Estradiol—Constipation—Vincristine—sarcoma	0.000294	0.00232	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Doxorubicin—sarcoma	0.000294	0.00232	CcSEcCtD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—MMP2—sarcoma	0.000291	0.00408	CbGpPWpGaD
Ethinyl Estradiol—Affect lability—Doxorubicin—sarcoma	0.000289	0.00228	CcSEcCtD
Ethinyl Estradiol—Migraine—Doxorubicin—sarcoma	0.000289	0.00228	CcSEcCtD
Ethinyl Estradiol—Fatigue—Mitoxantrone—sarcoma	0.000289	0.00228	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000289	0.00228	CcSEcCtD
Ethinyl Estradiol—Discomfort—Etoposide—sarcoma	0.000287	0.00227	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Epirubicin—sarcoma	0.000287	0.00227	CcSEcCtD
Ethinyl Estradiol—Constipation—Mitoxantrone—sarcoma	0.000286	0.00226	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Thiotepa—sarcoma	0.000286	0.00226	CcSEcCtD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—MMP2—sarcoma	0.000285	0.00401	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Dactinomycin—sarcoma	0.000284	0.00224	CcSEcCtD
Ethinyl Estradiol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000283	0.00398	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.000281	0.00395	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal pain—Vincristine—sarcoma	0.000281	0.00222	CcSEcCtD
Ethinyl Estradiol—Mood swings—Doxorubicin—sarcoma	0.000278	0.0022	CcSEcCtD
Ethinyl Estradiol—Asthenia—Thiotepa—sarcoma	0.000278	0.0022	CcSEcCtD
Ethinyl Estradiol—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000278	0.0039	CbGpPWpGaD
Ethinyl Estradiol—Infection—Etoposide—sarcoma	0.000277	0.00218	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Epirubicin—sarcoma	0.000276	0.00218	CcSEcCtD
Ethinyl Estradiol—Asthenia—Dactinomycin—sarcoma	0.000276	0.00218	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Mitoxantrone—sarcoma	0.000276	0.00218	CcSEcCtD
Ethinyl Estradiol—Pruritus—Thiotepa—sarcoma	0.000274	0.00217	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000274	0.00216	CcSEcCtD
Ethinyl Estradiol—NR1I2—Gene Expression—FUS—sarcoma	0.000273	0.00384	CbGpPWpGaD
Ethinyl Estradiol—Body temperature increased—Vincristine—sarcoma	0.000272	0.00215	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Vincristine—sarcoma	0.000272	0.00215	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Etoposide—sarcoma	0.000271	0.00214	CcSEcCtD
Ethinyl Estradiol—Urticaria—Mitoxantrone—sarcoma	0.000266	0.0021	CcSEcCtD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—FOXO1—sarcoma	0.000266	0.00373	CbGpPWpGaD
Ethinyl Estradiol—Breast disorder—Doxorubicin—sarcoma	0.000266	0.0021	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Thiotepa—sarcoma	0.000265	0.00209	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Mitoxantrone—sarcoma	0.000265	0.00209	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Mitoxantrone—sarcoma	0.000265	0.00209	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Epirubicin—sarcoma	0.000264	0.00208	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Dactinomycin—sarcoma	0.000263	0.00208	CcSEcCtD
Ethinyl Estradiol—Dysuria—Epirubicin—sarcoma	0.000257	0.00203	CcSEcCtD
Ethinyl Estradiol—Dizziness—Thiotepa—sarcoma	0.000256	0.00202	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Doxorubicin—sarcoma	0.000256	0.00202	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Epirubicin—sarcoma	0.000255	0.00201	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	0.000255	0.00358	CbGpPWpGaD
Ethinyl Estradiol—Pollakiuria—Epirubicin—sarcoma	0.000254	0.002	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Vincristine—sarcoma	0.000253	0.002	CcSEcCtD
Ethinyl Estradiol—ESR2—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000251	0.00352	CbGpPWpGaD
Ethinyl Estradiol—Weight increased—Epirubicin—sarcoma	0.00025	0.00197	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	0.00025	0.00351	CbGpPWpGaD
Ethinyl Estradiol—Weight decreased—Epirubicin—sarcoma	0.000248	0.00196	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Mitoxantrone—sarcoma	0.000247	0.00195	CcSEcCtD
Ethinyl Estradiol—Asthenia—Vincristine—sarcoma	0.000247	0.00195	CcSEcCtD
Ethinyl Estradiol—Vomiting—Thiotepa—sarcoma	0.000247	0.00195	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000245	0.00344	CbGpPWpGaD
Ethinyl Estradiol—Infestation—Epirubicin—sarcoma	0.000245	0.00193	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Epirubicin—sarcoma	0.000245	0.00193	CcSEcCtD
Ethinyl Estradiol—Vomiting—Dactinomycin—sarcoma	0.000245	0.00193	CcSEcCtD
Ethinyl Estradiol—Rash—Thiotepa—sarcoma	0.000244	0.00193	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Doxorubicin—sarcoma	0.000244	0.00193	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Thiotepa—sarcoma	0.000244	0.00193	CcSEcCtD
Ethinyl Estradiol—Headache—Thiotepa—sarcoma	0.000243	0.00192	CcSEcCtD
Ethinyl Estradiol—Rash—Dactinomycin—sarcoma	0.000243	0.00192	CcSEcCtD
Ethinyl Estradiol—ABCB1—uterus—sarcoma	0.000242	0.00443	CbGeAlD
Ethinyl Estradiol—Gastrointestinal disorder—Etoposide—sarcoma	0.00024	0.0019	CcSEcCtD
Ethinyl Estradiol—Asthenia—Mitoxantrone—sarcoma	0.00024	0.0019	CcSEcCtD
Ethinyl Estradiol—Fatigue—Etoposide—sarcoma	0.00024	0.0019	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Epirubicin—sarcoma	0.00024	0.00189	CcSEcCtD
Ethinyl Estradiol—Constipation—Etoposide—sarcoma	0.000238	0.00188	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Epirubicin—sarcoma	0.000238	0.00188	CcSEcCtD
Ethinyl Estradiol—Dysuria—Doxorubicin—sarcoma	0.000238	0.00188	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000236	0.00186	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Vincristine—sarcoma	0.000235	0.00186	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Doxorubicin—sarcoma	0.000235	0.00185	CcSEcCtD
Ethinyl Estradiol—CYP3A4—liver—sarcoma	0.000234	0.00429	CbGeAlD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—CREB1—sarcoma	0.000233	0.00328	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000233	0.00327	CbGpPWpGaD
Ethinyl Estradiol—Weight increased—Doxorubicin—sarcoma	0.000231	0.00183	CcSEcCtD
Ethinyl Estradiol—Nausea—Thiotepa—sarcoma	0.00023	0.00182	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Doxorubicin—sarcoma	0.00023	0.00181	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Epirubicin—sarcoma	0.00023	0.00181	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Etoposide—sarcoma	0.00023	0.00181	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Mitoxantrone—sarcoma	0.000229	0.00181	CcSEcCtD
Ethinyl Estradiol—Nausea—Dactinomycin—sarcoma	0.000229	0.0018	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Etoposide—sarcoma	0.000228	0.0018	CcSEcCtD
Ethinyl Estradiol—Dizziness—Vincristine—sarcoma	0.000227	0.00179	CcSEcCtD
Ethinyl Estradiol—Infestation—Doxorubicin—sarcoma	0.000227	0.00179	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Doxorubicin—sarcoma	0.000227	0.00179	CcSEcCtD
Ethinyl Estradiol—ABCB1—lymphoid tissue—sarcoma	0.000225	0.00413	CbGeAlD
Ethinyl Estradiol—Neuropathy peripheral—Doxorubicin—sarcoma	0.000222	0.00175	CcSEcCtD
Ethinyl Estradiol—Urticaria—Etoposide—sarcoma	0.000221	0.00175	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Epirubicin—sarcoma	0.000221	0.00174	CcSEcCtD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—CCND1—sarcoma	0.000221	0.0031	CbGpPWpGaD
Ethinyl Estradiol—Rhinitis—Epirubicin—sarcoma	0.00022	0.00174	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Etoposide—sarcoma	0.00022	0.00174	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Etoposide—sarcoma	0.00022	0.00174	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Doxorubicin—sarcoma	0.00022	0.00174	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Epirubicin—sarcoma	0.00022	0.00173	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Epirubicin—sarcoma	0.000219	0.00173	CcSEcCtD
Ethinyl Estradiol—Vomiting—Vincristine—sarcoma	0.000219	0.00173	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Epirubicin—sarcoma	0.000218	0.00172	CcSEcCtD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—MMP2—sarcoma	0.000217	0.00305	CbGpPWpGaD
Ethinyl Estradiol—Urinary tract disorder—Epirubicin—sarcoma	0.000217	0.00171	CcSEcCtD
Ethinyl Estradiol—Rash—Vincristine—sarcoma	0.000217	0.00171	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Vincristine—sarcoma	0.000217	0.00171	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Epirubicin—sarcoma	0.000216	0.0017	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Epirubicin—sarcoma	0.000215	0.0017	CcSEcCtD
Ethinyl Estradiol—Headache—Vincristine—sarcoma	0.000215	0.0017	CcSEcCtD
Ethinyl Estradiol—Vomiting—Mitoxantrone—sarcoma	0.000213	0.00168	CcSEcCtD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000213	0.00299	CbGpPWpGaD
Ethinyl Estradiol—Sinusitis—Doxorubicin—sarcoma	0.000213	0.00168	CcSEcCtD
Ethinyl Estradiol—ESR1—FOXA1 transcription factor network—JUN—sarcoma	0.000212	0.00298	CbGpPWpGaD
Ethinyl Estradiol—Visual impairment—Epirubicin—sarcoma	0.000212	0.00167	CcSEcCtD
Ethinyl Estradiol—Rash—Mitoxantrone—sarcoma	0.000211	0.00167	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Mitoxantrone—sarcoma	0.000211	0.00167	CcSEcCtD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000211	0.00296	CbGpPWpGaD
Ethinyl Estradiol—Headache—Mitoxantrone—sarcoma	0.00021	0.00166	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Epirubicin—sarcoma	0.000208	0.00164	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Epirubicin—sarcoma	0.000205	0.00162	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Etoposide—sarcoma	0.000205	0.00162	CcSEcCtD
Ethinyl Estradiol—ABCB1—bone marrow—sarcoma	0.000205	0.00376	CbGeAlD
Ethinyl Estradiol—Haemoglobin—Doxorubicin—sarcoma	0.000204	0.00161	CcSEcCtD
Ethinyl Estradiol—Nausea—Vincristine—sarcoma	0.000204	0.00161	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Doxorubicin—sarcoma	0.000204	0.00161	CcSEcCtD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—CREB1—sarcoma	0.000204	0.00286	CbGpPWpGaD
Ethinyl Estradiol—Haemorrhage—Doxorubicin—sarcoma	0.000203	0.00161	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000203	0.00285	CbGpPWpGaD
Ethinyl Estradiol—Hypoaesthesia—Doxorubicin—sarcoma	0.000202	0.0016	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Doxorubicin—sarcoma	0.000202	0.00159	CcSEcCtD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.000201	0.00283	CbGpPWpGaD
Ethinyl Estradiol—Urinary tract disorder—Doxorubicin—sarcoma	0.000201	0.00159	CcSEcCtD
Ethinyl Estradiol—Asthenia—Etoposide—sarcoma	0.0002	0.00158	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Doxorubicin—sarcoma	0.0002	0.00158	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Epirubicin—sarcoma	0.000199	0.00157	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Doxorubicin—sarcoma	0.000199	0.00157	CcSEcCtD
Ethinyl Estradiol—Nausea—Mitoxantrone—sarcoma	0.000199	0.00157	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Epirubicin—sarcoma	0.000199	0.00157	CcSEcCtD
Ethinyl Estradiol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.000197	0.00277	CbGpPWpGaD
Ethinyl Estradiol—Pruritus—Etoposide—sarcoma	0.000197	0.00156	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Doxorubicin—sarcoma	0.000196	0.00155	CcSEcCtD
Ethinyl Estradiol—Alopecia—Epirubicin—sarcoma	0.000194	0.00153	CcSEcCtD
Ethinyl Estradiol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000194	0.00273	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.000194	0.00272	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—CREB1—sarcoma	0.000193	0.00271	CbGpPWpGaD
Ethinyl Estradiol—Mental disorder—Epirubicin—sarcoma	0.000193	0.00152	CcSEcCtD
Ethinyl Estradiol—ESR2—Gene Expression—FUS—sarcoma	0.000192	0.0027	CbGpPWpGaD
Ethinyl Estradiol—Erythema multiforme—Doxorubicin—sarcoma	0.000192	0.00152	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Epirubicin—sarcoma	0.000191	0.00151	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Etoposide—sarcoma	0.000191	0.0015	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Doxorubicin—sarcoma	0.00019	0.0015	CcSEcCtD
Ethinyl Estradiol—Back pain—Epirubicin—sarcoma	0.000185	0.00146	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Doxorubicin—sarcoma	0.000184	0.00146	CcSEcCtD
Ethinyl Estradiol—Dizziness—Etoposide—sarcoma	0.000184	0.00145	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Epirubicin—sarcoma	0.000184	0.00145	CcSEcCtD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000184	0.00258	CbGpPWpGaD
Ethinyl Estradiol—Immune system disorder—Doxorubicin—sarcoma	0.000184	0.00145	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.000181	0.00254	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000181	0.00254	CbGpPWpGaD
Ethinyl Estradiol—Alopecia—Doxorubicin—sarcoma	0.00018	0.00142	CcSEcCtD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000179	0.00251	CbGpPWpGaD
Ethinyl Estradiol—Mental disorder—Doxorubicin—sarcoma	0.000178	0.00141	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Epirubicin—sarcoma	0.000178	0.0014	CcSEcCtD
Ethinyl Estradiol—Vomiting—Etoposide—sarcoma	0.000177	0.0014	CcSEcCtD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—MYC—sarcoma	0.000177	0.00249	CbGpPWpGaD
Ethinyl Estradiol—Malnutrition—Doxorubicin—sarcoma	0.000177	0.0014	CcSEcCtD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000177	0.00248	CbGpPWpGaD
Ethinyl Estradiol—Rash—Etoposide—sarcoma	0.000176	0.00139	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Etoposide—sarcoma	0.000175	0.00139	CcSEcCtD
Ethinyl Estradiol—ABCB1—testis—sarcoma	0.000175	0.00321	CbGeAlD
Ethinyl Estradiol—Headache—Etoposide—sarcoma	0.000174	0.00138	CcSEcCtD
Ethinyl Estradiol—ESR1—LKB1 signaling events—MYC—sarcoma	0.000174	0.00244	CbGpPWpGaD
Ethinyl Estradiol—Malaise—Epirubicin—sarcoma	0.000173	0.00136	CcSEcCtD
Ethinyl Estradiol—Back pain—Doxorubicin—sarcoma	0.000171	0.00135	CcSEcCtD
Ethinyl Estradiol—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000171	0.0024	CbGpPWpGaD
Ethinyl Estradiol—Muscle spasms—Doxorubicin—sarcoma	0.00017	0.00134	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	0.000168	0.00236	CbGpPWpGaD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—CCND1—sarcoma	0.000168	0.00236	CbGpPWpGaD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—JUN—sarcoma	0.000168	0.00236	CbGpPWpGaD
Ethinyl Estradiol—Cough—Epirubicin—sarcoma	0.000167	0.00132	CcSEcCtD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.000167	0.00234	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—liver—sarcoma	0.000166	0.00304	CbGeAlD
Ethinyl Estradiol—Nausea—Etoposide—sarcoma	0.000165	0.00131	CcSEcCtD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000165	0.00231	CbGpPWpGaD
Ethinyl Estradiol—Ill-defined disorder—Doxorubicin—sarcoma	0.000164	0.0013	CcSEcCtD
Ethinyl Estradiol—Anxiety—Epirubicin—sarcoma	0.000162	0.00128	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000162	0.00128	CcSEcCtD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000161	0.00226	CbGpPWpGaD
Ethinyl Estradiol—Discomfort—Epirubicin—sarcoma	0.000161	0.00127	CcSEcCtD
Ethinyl Estradiol—Malaise—Doxorubicin—sarcoma	0.00016	0.00126	CcSEcCtD
Ethinyl Estradiol—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000158	0.00221	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000157	0.00221	CbGpPWpGaD
Ethinyl Estradiol—Oedema—Epirubicin—sarcoma	0.000156	0.00123	CcSEcCtD
Ethinyl Estradiol—Infection—Epirubicin—sarcoma	0.000155	0.00122	CcSEcCtD
Ethinyl Estradiol—Cough—Doxorubicin—sarcoma	0.000154	0.00122	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—IL2—sarcoma	0.000154	0.00216	CbGpPWpGaD
Ethinyl Estradiol—Nervous system disorder—Epirubicin—sarcoma	0.000153	0.00121	CcSEcCtD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—JUN—sarcoma	0.000153	0.00215	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000152	0.00214	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000152	0.00213	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000152	0.00213	CbGpPWpGaD
Ethinyl Estradiol—Skin disorder—Epirubicin—sarcoma	0.000152	0.0012	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—FOXO1—sarcoma	0.000151	0.00212	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—PDGFRB—sarcoma	0.000151	0.00212	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	0.000151	0.00211	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—IL2—sarcoma	0.000151	0.00211	CbGpPWpGaD
Ethinyl Estradiol—Anxiety—Doxorubicin—sarcoma	0.00015	0.00119	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—CCND1—sarcoma	0.00015	0.00211	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—JUN—sarcoma	0.00015	0.0021	CbGpPWpGaD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00015	0.00118	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.00015	0.0021	CbGpPWpGaD
Ethinyl Estradiol—Discomfort—Doxorubicin—sarcoma	0.000149	0.00118	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—PDGFRA—sarcoma	0.000148	0.00208	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—CCND1—sarcoma	0.000147	0.00206	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—JUN—sarcoma	0.000146	0.00206	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—CTNNB1—sarcoma	0.000145	0.00204	CbGpPWpGaD
Ethinyl Estradiol—Oedema—Doxorubicin—sarcoma	0.000144	0.00114	CcSEcCtD
Ethinyl Estradiol—Infection—Doxorubicin—sarcoma	0.000144	0.00113	CcSEcCtD
Ethinyl Estradiol—ESR1—LKB1 signaling events—TP53—sarcoma	0.000143	0.002	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.000142	0.00199	CbGpPWpGaD
Ethinyl Estradiol—Nervous system disorder—Doxorubicin—sarcoma	0.000142	0.00112	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Doxorubicin—sarcoma	0.00014	0.00111	CcSEcCtD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—CCND1—sarcoma	0.000139	0.00195	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000135	0.00106	CcSEcCtD
Ethinyl Estradiol—Fatigue—Epirubicin—sarcoma	0.000135	0.00106	CcSEcCtD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000134	0.00188	CbGpPWpGaD
Ethinyl Estradiol—Constipation—Epirubicin—sarcoma	0.000134	0.00105	CcSEcCtD
Ethinyl Estradiol—ABCB1—Allograft Rejection—PDGFRA—sarcoma	0.000132	0.00186	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.00013	0.00183	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.00013	0.00183	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.00013	0.00183	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000129	0.00182	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000129	0.00181	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Epirubicin—sarcoma	0.000129	0.00102	CcSEcCtD
Ethinyl Estradiol—AOX1—Disease—TLE1—sarcoma	0.000128	0.0018	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal pain—Epirubicin—sarcoma	0.000128	0.00101	CcSEcCtD
Ethinyl Estradiol—ABCB1—lymph node—sarcoma	0.000127	0.00233	CbGeAlD
Ethinyl Estradiol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000126	0.00178	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000125	0.000985	CcSEcCtD
Ethinyl Estradiol—Fatigue—Doxorubicin—sarcoma	0.000125	0.000983	CcSEcCtD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—SRC—sarcoma	0.000124	0.00175	CbGpPWpGaD
Ethinyl Estradiol—Urticaria—Epirubicin—sarcoma	0.000124	0.000979	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000124	0.00174	CbGpPWpGaD
Ethinyl Estradiol—Constipation—Doxorubicin—sarcoma	0.000124	0.000975	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Epirubicin—sarcoma	0.000123	0.000974	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Epirubicin—sarcoma	0.000123	0.000974	CcSEcCtD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000123	0.00173	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—MYC—sarcoma	0.00012	0.00169	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Doxorubicin—sarcoma	0.000119	0.00094	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Doxorubicin—sarcoma	0.000118	0.000933	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—EGFR—sarcoma	0.000118	0.00165	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—MYC—sarcoma	0.000118	0.00165	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000117	0.00164	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—NPM1—sarcoma	0.000116	0.00162	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Epirubicin—sarcoma	0.000115	0.000908	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—KIT—sarcoma	0.000115	0.00162	CbGpPWpGaD
Ethinyl Estradiol—Urticaria—Doxorubicin—sarcoma	0.000115	0.000906	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Doxorubicin—sarcoma	0.000114	0.000902	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Doxorubicin—sarcoma	0.000114	0.000902	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000114	0.0016	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000113	0.00159	CbGpPWpGaD
Ethinyl Estradiol—Asthenia—Epirubicin—sarcoma	0.000112	0.000884	CcSEcCtD
Ethinyl Estradiol—Pruritus—Epirubicin—sarcoma	0.00011	0.000872	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.00011	0.00155	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—CREB1—sarcoma	0.000109	0.00154	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Epirubicin—sarcoma	0.000107	0.000843	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Doxorubicin—sarcoma	0.000106	0.00084	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000105	0.00147	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000105	0.00147	CbGpPWpGaD
Ethinyl Estradiol—Asthenia—Doxorubicin—sarcoma	0.000104	0.000818	CcSEcCtD
Ethinyl Estradiol—Dizziness—Epirubicin—sarcoma	0.000103	0.000815	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000102	0.00144	CbGpPWpGaD
Ethinyl Estradiol—Pruritus—Doxorubicin—sarcoma	0.000102	0.000807	CcSEcCtD
Ethinyl Estradiol—AOX1—Disease—ENO2—sarcoma	0.0001	0.00141	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Epirubicin—sarcoma	9.93e-05	0.000784	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Doxorubicin—sarcoma	9.88e-05	0.00078	CcSEcCtD
Ethinyl Estradiol—Rash—Epirubicin—sarcoma	9.84e-05	0.000777	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Epirubicin—sarcoma	9.84e-05	0.000776	CcSEcCtD
Ethinyl Estradiol—Headache—Epirubicin—sarcoma	9.78e-05	0.000772	CcSEcCtD
Ethinyl Estradiol—SLC10A1—Metabolism—ENO2—sarcoma	9.76e-05	0.00137	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—FUS—sarcoma	9.7e-05	0.00136	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—HBA1—sarcoma	9.7e-05	0.00136	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—TP53—sarcoma	9.66e-05	0.00136	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	9.66e-05	0.00136	CbGpPWpGaD
Ethinyl Estradiol—Dizziness—Doxorubicin—sarcoma	9.55e-05	0.000754	CcSEcCtD
Ethinyl Estradiol—Nausea—Epirubicin—sarcoma	9.27e-05	0.000732	CcSEcCtD
Ethinyl Estradiol—Vomiting—Doxorubicin—sarcoma	9.19e-05	0.000725	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	9.12e-05	0.00128	CbGpPWpGaD
Ethinyl Estradiol—Rash—Doxorubicin—sarcoma	9.11e-05	0.000719	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—MDM2—sarcoma	9.11e-05	0.00128	CbGpPWpGaD
Ethinyl Estradiol—Dermatitis—Doxorubicin—sarcoma	9.1e-05	0.000718	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—MDM2—sarcoma	9.06e-05	0.00127	CbGpPWpGaD
Ethinyl Estradiol—Headache—Doxorubicin—sarcoma	9.05e-05	0.000714	CcSEcCtD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—HRAS—sarcoma	8.75e-05	0.00123	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	8.59e-05	0.00121	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Doxorubicin—sarcoma	8.58e-05	0.000677	CcSEcCtD
Ethinyl Estradiol—AOX1—Disease—PLCG1—sarcoma	8.5e-05	0.00119	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—ENO2—sarcoma	8.39e-05	0.00118	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—HBA1—sarcoma	8.34e-05	0.00117	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	8.28e-05	0.00116	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PLCG1—sarcoma	8.28e-05	0.00116	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CXCR4—sarcoma	8.17e-05	0.00115	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	8.12e-05	0.00114	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—CCND1—sarcoma	7.93e-05	0.00111	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—JUN—sarcoma	7.92e-05	0.00111	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	7.86e-05	0.0011	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	7.68e-05	0.00108	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	7.55e-05	0.00106	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Generic Transcription Pathway—MYC—sarcoma	7.38e-05	0.00104	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—IL2—sarcoma	7.23e-05	0.00102	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PLCG1—sarcoma	7.12e-05	0.001	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	7.09e-05	0.000996	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	6.92e-05	0.000971	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—NRAS—sarcoma	6.79e-05	0.000954	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	6.57e-05	0.000923	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	6.56e-05	0.000921	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	6.54e-05	0.000918	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	6.51e-05	0.000914	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—MYC—sarcoma	6.36e-05	0.000894	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—EGFR—sarcoma	6.22e-05	0.000874	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—EGFR—sarcoma	6.19e-05	0.00087	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—VEGFA—sarcoma	6.14e-05	0.000863	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—FOXO1—sarcoma	6.03e-05	0.000847	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PDGFRB—sarcoma	6.02e-05	0.000846	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PDGFRA—sarcoma	5.93e-05	0.000833	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	5.88e-05	0.000826	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—KRAS—sarcoma	5.88e-05	0.000826	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—KRAS—sarcoma	5.85e-05	0.000821	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ENO2—sarcoma	5.75e-05	0.000808	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	5.73e-05	0.000805	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—HBA1—sarcoma	5.71e-05	0.000803	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	5.27e-05	0.000741	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—TP53—sarcoma	5.23e-05	0.000734	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—MYC—sarcoma	5.19e-05	0.00073	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	5.16e-05	0.000724	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—HRAS—sarcoma	4.97e-05	0.000698	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PLCG1—sarcoma	4.88e-05	0.000685	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	4.87e-05	0.000684	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	4.83e-05	0.000678	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—KIT—sarcoma	4.6e-05	0.000646	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CREB1—sarcoma	4.37e-05	0.000614	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	4.33e-05	0.000608	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TLE1—sarcoma	4.16e-05	0.000584	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	3.99e-05	0.000561	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MDM2—sarcoma	3.62e-05	0.000508	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—MYC—sarcoma	3.55e-05	0.000499	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—VEGFC—sarcoma	3.51e-05	0.000493	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	3.48e-05	0.000488	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	3.47e-05	0.000487	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	3.44e-05	0.000484	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CTNNB1—sarcoma	3.12e-05	0.000439	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	3.11e-05	0.000437	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	3.03e-05	0.000426	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—SRC—sarcoma	2.82e-05	0.000396	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—FLT1—sarcoma	2.8e-05	0.000394	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	2.79e-05	0.000392	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ENO2—sarcoma	2.79e-05	0.000391	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—HBA1—sarcoma	2.77e-05	0.000389	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PLCG1—sarcoma	2.76e-05	0.000387	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	2.73e-05	0.000383	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—NRAS—sarcoma	2.71e-05	0.000381	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CXCR4—sarcoma	2.65e-05	0.000372	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—MYC—sarcoma	2.62e-05	0.000368	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ATF1—sarcoma	2.62e-05	0.000368	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.58e-05	0.000362	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MYC—sarcoma	2.53e-05	0.000355	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—MYC—sarcoma	2.5e-05	0.000351	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—EGFR—sarcoma	2.47e-05	0.000347	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PLCG1—sarcoma	2.36e-05	0.000332	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ENO2—sarcoma	2.36e-05	0.000331	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—HBA1—sarcoma	2.34e-05	0.000329	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—KRAS—sarcoma	2.34e-05	0.000328	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.29e-05	0.000322	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ENO2—sarcoma	2.06e-05	0.000289	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IGF1R—sarcoma	2.05e-05	0.000289	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—HBA1—sarcoma	2.04e-05	0.000287	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PLCG1—sarcoma	2e-05	0.000281	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—HRAS—sarcoma	1.99e-05	0.000279	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—FOXO1—sarcoma	1.96e-05	0.000275	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PDGFRB—sarcoma	1.95e-05	0.000274	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PDGFRA—sarcoma	1.92e-05	0.00027	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PLCG1—sarcoma	1.74e-05	0.000245	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KDR—sarcoma	1.62e-05	0.000227	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KIT—sarcoma	1.49e-05	0.000209	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CREB1—sarcoma	1.42e-05	0.000199	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ENO2—sarcoma	1.27e-05	0.000178	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MYC—sarcoma	1.26e-05	0.000177	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—HBA1—sarcoma	1.26e-05	0.000177	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MDM2—sarcoma	1.17e-05	0.000165	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PLCG1—sarcoma	1.07e-05	0.000151	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL2—sarcoma	1.05e-05	0.000147	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCND1—sarcoma	1.02e-05	0.000144	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—JUN—sarcoma	1.02e-05	0.000143	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CTNNB1—sarcoma	1.01e-05	0.000142	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SRC—sarcoma	9.15e-06	0.000129	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—VEGFA—sarcoma	8.91e-06	0.000125	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NRAS—sarcoma	8.8e-06	0.000124	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MYC—sarcoma	8.2e-06	0.000115	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EGFR—sarcoma	8.02e-06	0.000113	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KRAS—sarcoma	7.57e-06	0.000106	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TP53—sarcoma	6.73e-06	9.46e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—HRAS—sarcoma	6.44e-06	9.04e-05	CbGpPWpGaD
